Circadian blood pressure variation and antihypertensive medication adjustment in normoalbuminuric type 2 diabetes patients

Kidney and Blood Pressure Research

Volumn 30, Issue 3, 2007, Pages 182-186

  Czupryniak, Leszek ^a   Pawłowski, MacIej ^a   Saryusz Wolska, Małgorzata ^a   Loba, Jerzy ^a  

^a Barlicki University Hospital No 1 ^*  (Poland)

Author keywords

Antihypertensive treatment; Blood pressure control; Circadian blood pressure variation; Hypertension; Type 2 diabetes mellitus

Indexed keywords

AMLODIPINE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; INDAPAMIDE; METFORMIN; NITRENDIPINE; PERINDOPRIL; SPIRONOLACTONE; SULFONYLUREA DERIVATIVE; TRANDOLAPRIL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE DIPPING; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BISOPROLOL; BLOOD PRESSURE; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION, RENAL; INDAPAMIDE; INDOLES; MALE; MIDDLE AGED; NITRENDIPINE; PERINDOPRIL; SPIRONOLACTONE;

EID: 34250810672     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103231     Document Type: Article

References (18)

1. Zachariah PK, Krier JD: Clinical uses of blood pressure monitoring. J Hypertens 1991;9(suppl 1):S7-S12.
2. Hojo Y, Noma S, Ohki T, Nakajima H, Satoh Y: Autonomic nervous system activity in essential hypertension: a comparison between dippers and non-dippers. J Hum Hypertens 1997;11:665-671.
3. Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, Nishizawa M, Kigoshi T, Kakinuma H, Takahashi H, Uchida K: Reversed circadian BP rhythm is associated with occurrences of both fatal and non-fatal vascular events in NIDDM subjects. Diabetes 1998;47:1501-1506.
4. Nakano Y, Oshima T, Ozono R, Higashi Y, Sasaki S, Matsumoto T, Matsuura H, Chayama K, Kambe M: Non-dipper phenomenon in essential hypertension is related to blunted nocturnal rise and fall of sympatho-vagal nervous activity and progress in retinopathy. Auton Neurosci 2001;8:181-186.
5. Mousa T, El-Sayed MA, Motawea AK, Salama MA, Elhendy A: Association of blunted nighttime blood pressure dipping with coronary artery stenosis in men. Am J Hypertens 2004;17:977-980.
6. Trazzi S, Mutti E, Frattola A, Imholz B, Parati G, Mancia G: Reproducibility of non-invasive and intra-arterial blood pressure monitoring. Implications for studies on anti-hypertensive treatment. J Hypertens 1991;9:115-119.
7. Stergiou GS, Mountokalakis TD: Detection of non-dipper hypertensives in clinical practice: does it really matter? Nephrol Dial Transplant 1999;14:2969-2970.
8. Rachmani R, Shenhav G, Slavachevsky I, Levy Z, Ravid M: Use of a mild sedative helps to identify true non-dippers by ABPM: a study in patients with diabetes mellitus and hypertension. Blood Press Monit 2004;9:65-69.
9. Hippisley-Cox J, Pringle M: Prevalence, care, and outcomes for patients with diet-controlled diabetes in general practice: cross-sectional survey. Lancet 2004;363:423-428.
10. Czupryniak L, Saryusz-Wolska M, Pawlowski M, Loba J: Elevated systolic blood pressure is present in almost all individuals with newly diagnosed diabetes mellitus. J Hum Hypertens 2006;20:231-233.
11. Chobanian AV, Bakris GL, Black HB, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccells EJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
12. Czupryniak L, Wiśniewska-Jarosińska M, Drzewoski J: Trandolapril restores circadian BP variation in normoalbuminuric normotensive type 1 diabetic patients. J Diabetes Complications 2001;15:75-79.
13. Jones CR, Taylor K, Chowienczyk P, Poston L, Shennan A: A validation of the Mobil-O-Graph (version 12) ambulatory BP monitor. Blood Pres Monit 2000;5:233-238.
14. The Scientific Committee: Consensus document on non-invasive ambulatory BP monitoring. J Hypertens 1990;8(suppl 6):S135-S140.
15. O'Brien E, Coats A, Owens P, Petrie J, Padfield PL, Littler WA, de Swiet M, Mee F: Use and interpretation of ambulatory BP monitoring: recommendations of the British Hypertension Society. BMJ 2000;320:1128-1134.
16. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P, on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring: European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003;21:821-848.
17. Verdecchia P: Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 2000;35:844-851.
18. Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D: Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997;96:308-315.